Profile
Pierre Langlade-Demoyen is currently the Chairman of Invectys SAS since 2010.
Pierre Langlade-Demoyen active positions
| Companies | Position | Start |
|---|---|---|
Invectys SAS
 Invectys SAS Pharmaceuticals: MajorHealth Technology Invectys SAS is a French company that specializes in cancer immunotherapeutics. The private company is based in Paris, France and was founded in 2010 by Pierre Demoyen. The company focuses on blocking immunosuppressive pathways using monoclonal antibodies and cancer to maintain homeostasis in the immune system. The company's goal is to induce the production of cancer-specific antigens in the patient's body through DNA vaccines. François Lescure has been the CEO of the company since 2022. | Chairman | 2010-05-14 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Invectys SAS
Invectys SAS Pharmaceuticals: MajorHealth Technology Invectys SAS is a French company that specializes in cancer immunotherapeutics. The private company is based in Paris, France and was founded in 2010 by Pierre Demoyen. The company focuses on blocking immunosuppressive pathways using monoclonal antibodies and cancer to maintain homeostasis in the immune system. The company's goal is to induce the production of cancer-specific antigens in the patient's body through DNA vaccines. François Lescure has been the CEO of the company since 2022. | Health Technology |
- Stock Market
- Insiders
- Pierre Langlade-Demoyen
